Wenbin Huang Selected Research

Wenbin Huang Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 03/2010
8	Carcinoma (Carcinomatosis) 01/2020 - 11/2008
8	Glaucoma 10/2016 - 01/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2005
6	Stomach Neoplasms (Stomach Cancer) 09/2019 - 03/2010
5	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 03/2016
5	Carcinogenesis 01/2021 - 10/2005
5	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 12/2018 - 01/2016
5	Cataract (Cataracts) 12/2018 - 02/2014
5	Open-Angle Glaucoma (Glaucoma, Open Angle) 05/2018 - 01/2013
4	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2012
4	Neovascular Glaucoma 01/2016 - 06/2013
3	Infections 04/2022 - 12/2021
3	Cleft Palate (Palate, Cleft) 02/2022 - 01/2020
3	Lung Neoplasms (Lung Cancer) 12/2021 - 06/2013
3	Inflammation (Inflammations) 01/2020 - 02/2014
3	Adenocarcinoma 05/2013 - 11/2008
2	Cleft Lip (Harelip) 12/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 07/2016
2	Breast Neoplasms (Breast Cancer) 11/2018 - 08/2018
2	Ocular Hypertension (Glaucoma, Suspect) 05/2018 - 02/2017
2	Hypoxia (Hypoxemia) 06/2016 - 01/2016
1	Pathologic Processes 05/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Pain (Aches) 01/2020
1	Van der Woude syndrome 01/2020
1	Erythema 01/2020
1	Adenoma (Adenomas) 08/2018
1	Neuroinflammatory Diseases 02/2017
1	Necrosis 02/2017
1	Transitional Cell Carcinoma 01/2016

Drug/Important Bio-Agent (IBA)

9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 06/2013
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2010
3	CytokinesIBA 12/2018 - 02/2014
2	Biological ProductsIBA 05/2022 - 01/2016
2	VaccinesIBA 04/2022 - 12/2021
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2022 - 11/2019
2	Sulfonylurea ReceptorsIBA 01/2022 - 11/2019
2	Cadherins (E-Cadherin)IBA 01/2020 - 03/2012
2	Messenger RNA (mRNA)IBA 01/2020 - 10/2013
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 11/2019
2	CateninsIBA 01/2019 - 05/2013
2	Eukaryotic Initiation Factor-4EIBA 01/2019 - 12/2017
2	Cyclin D1IBA 01/2019 - 10/2013
2	Indicators and Reagents (Reagents)IBA 11/2018 - 03/2010
2	Retinaldehyde (Retinal)IBA 02/2017 - 06/2013
2	Ranibizumab (Lucentis)FDA Link 01/2016 - 01/2014
1	AntigensIBA 04/2022
1	Peptides (Polypeptides)IBA 04/2022
1	Arginine (L-Arginine)FDA Link 02/2022
1	Conditioned Culture MediaIBA 01/2022
1	snRNP Core ProteinsIBA 12/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	dapagliflozinIBA 01/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020
1	InterferonsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	KinesinsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	B7-H1 AntigenIBA 09/2019
1	trioctyl phosphine oxide (TOPO)IBA 11/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2018
1	Mitogen-Activated Protein KinasesIBA 08/2018
1	cytoplasmic protein A (PACD)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 02/2017
1	MicroRNAs (MicroRNA)IBA 02/2017
1	Cisplatin (Platino)FDA LinkGeneric 07/2016
1	PolyphenolsIBA 07/2016
1	PlatinumIBA 07/2016
1	Copper Transporter 1IBA 07/2016
1	TeaIBA 07/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2016
1	CC ChemokinesIBA 05/2016
1	LigandsIBA 05/2016
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 03/2016
1	Tumor Biomarkers (Tumor Markers)IBA 03/2016
1	MagnesiumIBA 03/2016
1	ArgonIBA 01/2016
1	Placenta Growth FactorIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016

Therapy/Procedure

5	Therapeutics 11/2019 - 12/2012
5	Trabeculectomy (Trabeculoplasty) 12/2018 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 07/2016
3	Intravitreal Injections 01/2016 - 06/2013
2	Filtering Surgery 10/2016 - 05/2016
1	Critical Care (Surgical Intensive Care) 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Neoadjuvant Therapy 11/2018
1	Cannula 02/2017